Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Other Working Capital Changes (2019 - 2026)

Immatics (IMTX) posted Other Working Capital Changes of -$5.3 million for Q4 2025, down 254.73% sequentially from -$1.5 million in Q3 2025, and down 870.14% YoY from $688175.4 in Q4 2024.

Analysis

Immatics (IMTX) Other Working Capital Changes (2019 - 2026) Analysis & Trends

Immatics has reported Other Working Capital Changes for 7 years, with the latest figure at -$5.3 million in Q4 2025.

  • Quarterly Other Working Capital Changes fell 870.14% year-over-year to -$5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$7.1 million (down 1017.67% YoY) and the FY2025 annual result came in at -$6.9 million, down 977.02% from the prior year.
  • Other Working Capital Changes slipped to -$5.3 million in Q4 2025 per IMTX's latest filing, from -$1.5 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $729681.4 in Q4 2020 and troughed at -$7.1 million in Q2 2022.
  • A 5-year average of -$993353.4 and a median of -$263749.4 in 2022 frame the typical range for Other Working Capital Changes.
  • The sharpest annual moves came in 2021 and 2025: Other Working Capital Changes surged 453.58% in 2021, then slumped 870.14% in 2025.
  • Over 5 years, Other Working Capital Changes stood at -$367302.8 in 2021, then sank by 1486.05% to -$5.8 million in 2022, then soared by 182.19% to $4.8 million in 2023, then tumbled by 85.63% to $688175.4 in 2024, then plunged by 870.14% to -$5.3 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$5.3 million, -$1.5 million, and -$211676.5 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Immatics 1.17 Bn 711.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -840,387.62
Jun 30, 2026 -840,387.62
Mar 31, 2026 -889,766.69
Mar 31, 2026 -889,766.69
Dec 31, 2025 -870,704.55
Dec 31, 2025 -870,704.55
Sep 30, 2025 -862,762.66
Sep 30, 2025 -862,762.66
Jun 30, 2025 -833,122.33
Jun 30, 2025 -833,122.33
Mar 31, 2025 -775,238.83
Mar 31, 2025 -775,238.83
Dec 31, 2024 -837,778.79
Dec 31, 2024 -837,778.79
Sep 30, 2024 -912,620.41
Sep 30, 2024 -912,620.41
Dec 31, 2020 -170,497.45
Dec 31, 2020 -170,497.45
Mar 31, 2020 760,613.99
Mar 31, 2020 760,613.99